Publication Information

{'id': 'https://openalex.org/W2189137086', 'doi': None, 'title': 'Antiproliferative and antitumor effects of azacitidine against the human myelodysplastic syndrome cell line SKM-1.', 'display_name': 'Antiproliferative and antitumor effects of azacitidine against the human myelodysplastic syndrome cell line SKM-1.', 'publication_year': 2012, 'publication_date': '2012-03-01', 'ids': {'openalex': 'https://openalex.org/W2189137086', 'mag': '2189137086', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/22399596'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/22399596', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5109949988', 'display_name': 'Sachie Kimura', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210162696', 'display_name': 'Nippon Shinyaku (Japan)', 'ror': 'https://ror.org/05wyn3p10', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210162696']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Sachie Kimura', 'raw_affiliation_strings': ['Exploratory Department, Discovery Research Laboratories, Nippon Shinyaku Co., Ltd., 14, Nishinosho-monguchi-cho, Kisshoin, Minami-ku, Kyoto 601-8550, Japan. [email protected]'], 'affiliations': [{'raw_affiliation_string': 'Exploratory Department, Discovery Research Laboratories, Nippon Shinyaku Co., Ltd., 14, Nishinosho-monguchi-cho, Kisshoin, Minami-ku, Kyoto 601-8550, Japan. [email protected]', 'institution_ids': ['https://openalex.org/I4210162696']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101444191', 'display_name': 'Kazuya Kuramoto', 'orcid': 'https://orcid.org/0000-0003-1637-5918'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Kazuya Kuramoto', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5067532679', 'display_name': 'Junko Homan', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Junko Homan', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5076862513', 'display_name': 'Haruna Naruoka', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Haruna Naruoka', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5045018777', 'display_name': 'Takeshi Ego', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Takeshi Ego', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5013026415', 'display_name': 'Masaki Nogawa', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Masaki Nogawa', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5004006571', 'display_name': 'Seishi Sugahara', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Seishi Sugahara', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5113999944', 'display_name': 'Haruna Naito', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Haruna Naito', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 2.216, 'has_fulltext': False, 'cited_by_count': 31, 'citation_normalized_percentile': {'value': 0.936441, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 92, 'max': 93}, 'biblio': {'volume': '32', 'issue': '3', 'first_page': '795', 'last_page': '8'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10309', 'display_name': 'Acute Myeloid Leukemia Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10309', 'display_name': 'Acute Myeloid Leukemia Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10269', 'display_name': 'Epigenetics and DNA Methylation', 'score': 0.9992, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10950', 'display_name': 'Acute Lymphoblastic Leukemia research', 'score': 0.9895, 'subfield': {'id': 'https://openalex.org/subfields/2739', 'display_name': 'Public Health, Environmental and Occupational Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/azacitidine', 'display_name': 'Azacitidine', 'score': 0.98284674}, {'id': 'https://openalex.org/keywords/decitabine', 'display_name': 'Decitabine', 'score': 0.92582333}, {'id': 'https://openalex.org/keywords/hypomethylating-agent', 'display_name': 'Hypomethylating agent', 'score': 0.5322722}, {'id': 'https://openalex.org/keywords/demethylating-agent', 'display_name': 'Demethylating agent', 'score': 0.47852242}], 'concepts': [{'id': 'https://openalex.org/C2776239401', 'wikidata': 'https://www.wikidata.org/wiki/Q416451', 'display_name': 'Azacitidine', 'level': 5, 'score': 0.98284674}, {'id': 'https://openalex.org/C2780235182', 'wikidata': 'https://www.wikidata.org/wiki/Q1181878', 'display_name': 'Decitabine', 'level': 5, 'score': 0.92582333}, {'id': 'https://openalex.org/C2780817109', 'wikidata': 'https://www.wikidata.org/wiki/Q954625', 'display_name': 'Myelodysplastic syndromes', 'level': 3, 'score': 0.7938007}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.64056426}, {'id': 'https://openalex.org/C2776012956', 'wikidata': 'https://www.wikidata.org/wiki/Q17125294', 'display_name': 'Hypomethylating agent', 'level': 5, 'score': 0.5322722}, {'id': 'https://openalex.org/C2778041864', 'wikidata': 'https://www.wikidata.org/wiki/Q180983', 'display_name': 'Cytarabine', 'level': 3, 'score': 0.48763838}, {'id': 'https://openalex.org/C2779277951', 'wikidata': 'https://www.wikidata.org/wiki/Q5255196', 'display_name': 'Demethylating agent', 'level': 5, 'score': 0.47852242}, {'id': 'https://openalex.org/C190727270', 'wikidata': 'https://www.wikidata.org/wiki/Q874745', 'display_name': 'DNA methylation', 'level': 4, 'score': 0.4632799}, {'id': 'https://openalex.org/C62112901', 'wikidata': 'https://www.wikidata.org/wiki/Q189159', 'display_name': 'Cell growth', 'level': 2, 'score': 0.44595575}, {'id': 'https://openalex.org/C2778729363', 'wikidata': 'https://www.wikidata.org/wiki/Q11688946', 'display_name': 'Myeloid leukemia', 'level': 2, 'score': 0.44358513}, {'id': 'https://openalex.org/C2778461978', 'wikidata': 'https://www.wikidata.org/wiki/Q29496', 'display_name': 'Leukemia', 'level': 2, 'score': 0.42844078}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.36955014}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.3422044}, {'id': 'https://openalex.org/C2780007613', 'wikidata': 'https://www.wikidata.org/wiki/Q546523', 'display_name': 'Bone marrow', 'level': 2, 'score': 0.27758104}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.2572607}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.074398726}, {'id': 'https://openalex.org/C150194340', 'wikidata': 'https://www.wikidata.org/wiki/Q26972', 'display_name': 'Gene expression', 'level': 3, 'score': 0.0}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D001374', 'descriptor_name': 'Azacitidine', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D049109', 'descriptor_name': 'Cell Proliferation', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D009190', 'descriptor_name': 'Myelodysplastic Syndromes', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': True}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001374', 'descriptor_name': 'Azacitidine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D045744', 'descriptor_name': 'Cell Line, Tumor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D049109', 'descriptor_name': 'Cell Proliferation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D050762', 'descriptor_name': 'Cyclin-Dependent Kinase Inhibitor p15', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D050762', 'descriptor_name': 'Cyclin-Dependent Kinase Inhibitor p15', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019175', 'descriptor_name': 'DNA Methylation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009190', 'descriptor_name': 'Myelodysplastic Syndromes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/22399596', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.81}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 18, 'referenced_works': ['https://openalex.org/W1487738309', 'https://openalex.org/W1605230984', 'https://openalex.org/W1607145333', 'https://openalex.org/W1970772467', 'https://openalex.org/W1977361366', 'https://openalex.org/W2008731424', 'https://openalex.org/W2016247404', 'https://openalex.org/W2025346428', 'https://openalex.org/W2103771397', 'https://openalex.org/W2106584820', 'https://openalex.org/W2106833395', 'https://openalex.org/W2107933884', 'https://openalex.org/W2118771330', 'https://openalex.org/W2134087142', 'https://openalex.org/W2143319558', 'https://openalex.org/W2334378889', 'https://openalex.org/W2354344320', 'https://openalex.org/W3135158967'], 'related_works': ['https://openalex.org/W4286817035', 'https://openalex.org/W2890675879', 'https://openalex.org/W2621092371', 'https://openalex.org/W2530906933', 'https://openalex.org/W2436188093', 'https://openalex.org/W2189137086', 'https://openalex.org/W2122782605', 'https://openalex.org/W2015362001', 'https://openalex.org/W2015013719', 'https://openalex.org/W1996917824'], 'abstract_inverted_index': {'The': [0, 30], 'myelodysplastic': [1], 'syndromes': [2], '(MDS)': [3], 'are': [4], 'a': [5, 22, 35, 72], 'group': [6], 'of': [7, 14, 24, 47, 54, 81, 122], 'stem': [8], 'cell': [9, 19, 59, 68, 108], 'disorders': [10], 'characterized': [11], 'by': [12, 64, 125], 'dysplasia': [13], 'one': [15], 'or': [16], 'more': [17], 'hematopoietic': [18], 'lineages': [20], 'and': [21, 71, 77, 103, 131, 137], 'risk': [23], 'progression': [25], 'to': [26, 128], 'acute': [27], 'myeloid': [28], 'leukemia.': [29], 'cytidine': [31], 'analog': [32, 98], 'azacitidine': [33, 55, 117, 126], '(Vidaza),': [34], 'hypomethylating': [36], 'agent,': [37], 'improves': [38], 'survival': [39], 'in': [40, 92, 110, 143], 'patients': [41], 'with': [42], 'MDS,': [43], 'but': [44], 'its': [45, 129, 140], 'mechanism': [46], 'action': [48], 'is': [49], 'not': [50], 'well': [51], 'understood.The': [52], 'effects': [53, 133], 'on': [56], 'the': [57, 82, 96, 113], 'MDS-derived': [58], 'line': [60], 'SKM-1': [61, 93, 107, 135], 'were': [62], 'investigated': [63], 'DNA': [65, 123], 'methylation': [66], 'assay,': [67, 70], 'proliferation': [69], 'subcutaneous': [73], 'xenograft': [74, 115], 'mouse': [75, 114], 'model.Azacitidine': [76], 'decitabine': [78, 104], 'induced': [79], 'hypomethylation': [80], 'tumor': [83, 120], 'suppressor': [84], 'gene': [85], 'cyclin-dependent': [86], 'kinase': [87], '4': [88], 'inhibitor': [89], 'B': [90], '(CDKN2B)': [91], 'cells,': [94], 'whereas': [95], 'deoxycytidine': [97], 'cytarabine': [99], 'did': [100], 'not.': [101], 'Azacitidine': [102], 'also': [105], 'inhibited': [106], 'growth': [109], 'vitro.': [111], 'In': [112], 'model,': [116], 'significantly': [118], 'suppressed': [119], 'growth.Inhibition': [121], 'methyltransferase': [124], 'contributes': [127], 'antiproliferative': [130], 'antitumor': [132], 'against': [134], 'cells': [136], 'may': [138], 'explain': [139], 'clinical': [141], 'efficacy': [142], 'MDS.': [144]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2189137086', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 2}, {'year': 2021, 'cited_by_count': 4}, {'year': 2020, 'cited_by_count': 3}, {'year': 2019, 'cited_by_count': 2}, {'year': 2017, 'cited_by_count': 2}, {'year': 2016, 'cited_by_count': 3}, {'year': 2015, 'cited_by_count': 5}, {'year': 2014, 'cited_by_count': 2}, {'year': 2013, 'cited_by_count': 3}, {'year': 2012, 'cited_by_count': 3}], 'updated_date': '2024-12-09T22:17:10.048075', 'created_date': '2016-06-24'}